Treatment of chronic hepatitis C
Related Experiment Video
Updated: Oct 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
11st Medical Department, University of Mainz, Federal Republic of Germany.
Abstract:
alpha-Interferon given subcutaneously at doses between 1-3 million units leads to responses in about 50% of patients suffering from chronic hepatitis C. A 24-week treatment is frequently (approx. 50%) followed by relapses reducing the percentage of lasting responders to approx. 20%. The patients who relapse are sensitive to retreatment with interferon-alpha. A better understanding of HCV replication and of the interferon action in this viral disease might help to further improve treatment schedules. Side effects of interferon were frequently mild and readily reversible after cessation of treatment. At present interferon treatment should not be recommended in asymptomatic patients or individuals with slowly progressive liver disease.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

